1. Home
  2. DVA vs ALB Comparison

DVA vs ALB Comparison

Compare DVA & ALB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • ALB
  • Stock Information
  • Founded
  • DVA 1994
  • ALB 1994
  • Country
  • DVA United States
  • ALB United States
  • Employees
  • DVA N/A
  • ALB N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • ALB Major Chemicals
  • Sector
  • DVA Health Care
  • ALB Industrials
  • Exchange
  • DVA Nasdaq
  • ALB Nasdaq
  • Market Cap
  • DVA 9.4B
  • ALB 10.8B
  • IPO Year
  • DVA 1995
  • ALB 1994
  • Fundamental
  • Price
  • DVA $119.80
  • ALB $124.97
  • Analyst Decision
  • DVA Hold
  • ALB Hold
  • Analyst Count
  • DVA 4
  • ALB 18
  • Target Price
  • DVA $145.00
  • ALB $91.59
  • AVG Volume (30 Days)
  • DVA 957.9K
  • ALB 3.7M
  • Earning Date
  • DVA 10-29-2025
  • ALB 11-05-2025
  • Dividend Yield
  • DVA N/A
  • ALB 1.41%
  • EPS Growth
  • DVA 5.63
  • ALB N/A
  • EPS
  • DVA 9.76
  • ALB N/A
  • Revenue
  • DVA $13,317,965,000.00
  • ALB $4,946,415,000.00
  • Revenue This Year
  • DVA $6.24
  • ALB N/A
  • Revenue Next Year
  • DVA $3.32
  • ALB $6.23
  • P/E Ratio
  • DVA $12.45
  • ALB N/A
  • Revenue Growth
  • DVA 5.14
  • ALB N/A
  • 52 Week Low
  • DVA $115.39
  • ALB $49.43
  • 52 Week High
  • DVA $179.60
  • ALB $119.28
  • Technical
  • Relative Strength Index (RSI)
  • DVA 38.86
  • ALB 75.04
  • Support Level
  • DVA $118.75
  • ALB $107.63
  • Resistance Level
  • DVA $125.68
  • ALB $119.28
  • Average True Range (ATR)
  • DVA 3.56
  • ALB 5.37
  • MACD
  • DVA 0.10
  • ALB 2.45
  • Stochastic Oscillator
  • DVA 27.09
  • ALB 96.94

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About ALB Albemarle Corporation

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.

Share on Social Networks: